Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies.

IF 4.9 Q2 ENDOCRINOLOGY & METABOLISM

Journal of Diabetes Science and Technology Pub Date : 2026-09-01 Epub Date: 2025-04-10 DOI:10.1177/19322968251332956

Davida F Kruger, Christopher G Parkin, Irl B Hirsch, Grazia Aleppo, Janet B McGill, Rodolfo J Galindo, Carol J Levy, Guillermo E Umpierrez, George Grunberger, Richard M Bergenstal

引用次数: 0

Abstract

The use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) technologies can improve patient outcomes and overall quality of life while helping to reduce the long-term costs. However, current eligibility criteria imposed by many major commercial insurers limit access to these technologies among a large portion of the diabetes population. This narrative review and commentary highlights the evidence supporting the use of CGM and AID in the various diabetes populations, discuss the current eligibility criteria that make these technologies inaccessible to individuals who would benefit, and present recommendations for modifying these criteria.

查看原文本刊更多论文

应对糖尿病海啸需要扩大获得糖尿病技术的途径。

使用连续血糖监测（CGM）和自动胰岛素输送（AID）技术可以改善患者的预后和整体生活质量，同时有助于降低长期成本。然而，目前许多主要商业保险公司制定的资格标准限制了大部分糖尿病人群获得这些技术。这篇叙述性综述和评论强调了支持在各种糖尿病人群中使用CGM和AID的证据，讨论了目前的资格标准，这些标准使受益的个体无法获得这些技术，并提出了修改这些标准的建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Diabetes Science and Technology Medicine-Internal Medicine

CiteScore

7.50

自引率

12.00%

发文量

148

期刊介绍： The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.